CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Neurology
Reviewed By
Dr Noyce is a reader in Neurology and Neuroepidemiology in the Centre for Preventive, Detection and Diagnosis (CPDD), the Wolfson Institute of Population Health, and Queen Mary University of London (QMUL).
He graduated from Barts and the London (QMUL) in 2007 and pursued integrated training via the Foundation Academic Programme and an NIHR Academic Clinical Fellowship at UCL. Dr Noyce undertook a PhD in Neuroscience at UCL and an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine. Following this, he re-joined QMUL and the PNU in 2017 to lead the Parkinson’s programme of work.
His research interests are Parkinson’s disease and other neurodegenerative disorders, particularly early identification and epidemiological aspects, including environmental, clinical and genetic determinants.
This consultant doesn't have any procedures information at the moment.
English
MBBS, BMedSci, MRCP, MSc, PhD, FHEA
General Medical Council: 6160721
New appointment: £275
Follow-up appointment: £175
Reviewed By